The financials
Lumexa Imaging Holdings, Inc. by the numbers
Lumexa Imaging Holdings, Inc. (LMRI) reported revenue of $264M in Q2 2026 (quarter ended June 30, 2026), up 7.8% from the same quarter a year earlier. That came with net income of $2.7M (1.0% of revenue). Its largest product in 2026-Q1 was Health Care Patient Service at $189M, 79% of the disclosed total, just ahead of Management Fee And Other at 15%.
| Income statement | Q2 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | $264M | $245M | +7.8% |
| Operating income | $23M | $26M | −9.8% |
| Net income | $2.7M | −$7.7M | to a profit |
| Diluted EPS | $0.03 | −$0.11 | to a profit |
| Product | Revenue | Share |
|---|---|---|
| Health Care Patient Service | $189M | 79% |
| Management Fee And Other | $36M | 15% |
| Patient Service Revenue Related Party | $8.3M | 3.5% |
| Investment Advisory Management And Administrative Service | $5.7M | 2.4% |
Business Segments
Revenue split by product segment, from SEC XBRL filings.
Latest period: Q1 2026Total $238.5M (+3.0%)
Segment Latestquarter on quarteryear on year
- Health Care Patient Service$189.0M$189.0MQoQ +2.6%year on year +2.6%+2.6%+2.6%
- Management Fee And Other$35.5M$35.5MQoQ +4.4%year on year +4.4%+4.4%+4.4%
- Patient Service Revenue Related Party$8.3M$8.3MQoQ +3.0%year on year +3.0%+3.0%+3.0%
- Investment Advisory Management And Administrative Service$5.7M$5.7MQoQ +6.7%year on year +6.7%+6.7%+6.7%
Medical Devices
The closest names by size in the same industry